Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone-impregnated CMC Foam vs Steroid Eluting Implant in Nasal Polyposis Surgery
NCT03607175Phase 3Not yet recruiting
- Start
- Jul 2023
- Primary completion
- Sep 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of triamcinolone acetonide in nasal polyposis, chronic rhinosinusitis (CRS). Planned start Jul 2023; status: not yet recruiting.
02
Drugs
triamcinolone acetonide
03
Conditions
nasal polyposischronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT03607175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03607175.